Insigneo Advisory Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.66M | Buy |
24,099
+14,977
| +164% | +$1.03M | 0.14% | 129 |
|
|
2025
Q1 | $633K | Sell |
9,122
-3,237
| -26% | -$225K | 0.07% | 244 |
|
|
2024
Q4 | $1.06M | Buy |
12,359
+412
| +3% | +$35.4K | 0.11% | 157 |
|
|
2024
Q3 | $1.42M | Buy |
11,947
+1,254
| +12% | +$149K | 0.14% | 140 |
|
|
2024
Q2 | $1.35M | Buy |
10,693
+108
| +1% | +$13.6K | 0.15% | 133 |
|
|
2024
Q1 | $1.37M | Buy |
10,585
+5,122
| +94% | +$662K | 0.16% | 121 |
|
|
2023
Q4 | $565K | Buy |
5,463
+859
| +19% | +$88.9K | 0.08% | 221 |
|
|
2023
Q3 | $419K | Buy |
4,604
+238
| +5% | +$21.6K | 0.09% | 220 |
|
|
2023
Q2 | $353K | Buy |
4,366
+304
| +7% | +$24.6K | 0.07% | 251 |
|
|
2023
Q1 | $326K | Buy |
4,062
+154
| +4% | +$12.3K | 0.1% | 196 |
|
|
2022
Q4 | $264K | Buy |
+3,908
| New | +$264K | 0.1% | 209 |
|